NewsBenzingaSweetgreen Q2 2026 Earnings Call: Complete Transcript Sweetgreen Q2 2026 Earnings Call: Complete Transcript Benzinga 2026.10.05 09:02 (GMT+0) Open on Benzinga Other news BMO Capital Maintains Market Perform on BILL Holdings, Lowers Price Target to $63.25 Merck Reports Positive Survival Data For Investigational Therapy for Advanced Gastric Cancer BMO Capital Maintains Market Perform on Bath & Body Works, Lowers Price Target to $20 Buckle Posts Strong Q3 Results, Joins Evolent Health, Bending Spoons And Other Big Stocks Moving Higher On Friday BMO Capital Maintains Outperform on Palo Alto Networks, Raises Price Target to $425 BMO Capital Maintains Outperform on Alnylam Pharmaceuticals, Raises Price Target to $293
Buckle Posts Strong Q3 Results, Joins Evolent Health, Bending Spoons And Other Big Stocks Moving Higher On Friday